TGA's low value turnover exemption scheme under review
17 April, 2014The Therapeutic Goods Administration (TGA) has announced a review of the low value turnover exemption scheme (LVT scheme), which exempts cost recovery fees on products with low turnover.
Queensland Government to inject $1m into MRCF
17 April, 2014 by Dylan Bushell-EmblingThe Queensland Government will kick another $1m into the Medical Research Commercialisation Fund (MRCF), a VC fund jointly supported by the federal, Qld, Vic, NSW and WA governments.
Nexvet raises $33.6m in financing round
17 April, 2014 by Dylan Bushell-EmblingNexvet Biopharma will put the proceeds of a $33.6m Series B financing round to funding key clinical trials for its lead products, as well as expanding its development pipeline and US presence.
ResMed gets Red Dots for respiratory products
15 April, 2014 by Dylan Bushell-EmblingResMed (ASX:RMD) has secured Red Dot designation for a nasal pillow mask and a soon-to-be-launched life support ventilator at this year's awards.
pSivida partner gets new PDUFA date
15 April, 2014 by Dylan Bushell-EmblingThe US FDA has set a PDUFA date of 26 September for pSivida (ASX:PVA) partner Alimera Sciences' fourth new drug application for diabetic macular edema treatment Iluvien.
Program announced for 2014 global agri-biotech conference in Canada
15 April, 2014This year's Agricultural Biotechnology International Conference (ABIC) has launched its program. Registrations are now open for the event, to be held from 5-8 October in Saskatoon, Saskatchewan, Canada.
Reforming Employee Share Schemes for the good of start-up innovation
14 April, 2014 by Dr Anna LavelleAn effective employee share scheme would enable start-up companies to attract and retain the quality employees they need to become established successful ventures.
Spinifex raises $48m for pain drug trials
11 April, 2014 by Dylan Bushell-EmblingUQ spinoff Spinifex has raised $47.7m in series C investment funding to help accelerate the clinical development of neuropathic and inflammatory pain drug EMA401.
Osprey's pilot diabetic limb trial a success
10 April, 2014 by Dylan Bushell-EmblingOsprey Medical's (ASX:OSP) Limb Recovery System reduced bacterial load in patients with diabetic foot infections during a pilot trial - so much so that one patient escaped the need for amputation.
CEO focus groups gather leaders' views
10 April, 2014Biotech and medtech leaders are participating this week and next in focus groups to share their views and perspectives on industry policy and bolster the 2014 Biotechnology Industry Position Survey, due for release in May.
Avita Medical improves ReCell Spray-on Skin
09 April, 2014 by Dylan Bushell-EmblingAvita Medical (ASX:AVH) announced the EU launch of a version of its ReCell Spray-on Skin that eliminates the requirement for refrigeration, but the new version is not yet approved in Australia.
'Soft Landing' program to support access to Hong Kong and China
08 April, 2014Hong Kong's 'Soft-landing Programme for Technology and Innovation Collaboration' is open to technology transfer offices (TTOs), research and development centres, research institutes and spin-out companies of overseas universities interested in exploring the Asian market, especially mainland China.
GI Dynamics scores Israeli win for EndoBarrier
08 April, 2014 by Dylan Bushell-EmblingGI Dynamics (ASX:GID) has revealed that its EndoBarrier therapy now has reimbursement coverage at one of Israel's four HMOs, and is now on offer at two more Australian clinics.
Reva fixed in focus on Fantom
07 April, 2014Reva sticks to expediting its biodegradable stent Fantom to the clinic.
Global Kinetics to present at philanthropic forum
07 April, 2014 by Dylan Bushell-EmblingMelbourne's Global Kinetics will present details of the company and its Parkinson's Kinetograph symptom-monitoring device at a global philanthropic forum in New York in May.
